Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...
We recently compiled a list of the These 10 Firms Were Last Week’s Worst Performers. In this article, we are going to take a ...
We recently compiled a list of the 12 Best Healthcare Stocks to Buy According to Analysts. In this article, we are going to ...
An image that is spreading widely online claims that Moderna had created its COVID-19 vaccine two years before the pandemic ...
An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...
There are currently three vaccine candidates moving through the clinical pipeline in human trials right now, and the furthest along is Moderna, which has developed a norovirus vaccine with the ...
Is Moderna, Inc. (MRNA) The Stock That Will Go to the Moon According to Reddit? A scientist surrounded by vials and beakers in a modern laboratory, proudly displaying a vaccine. However ...
Shares of Moderna plunged 20% Monday after the vaccine maker slashed its forecast of full-year 2025 revenue, as sales of its vaccines against Covid-19 and respiratory syncytial virus continue to ...
While the virus hasn’t made a sustained leap into humans, vaccines and treatments are being developed ahead of an outbreak.
Moderna Inc. shares plunged after the company slashed its sales forecast for this year as it struggles with slow demand for its Covid and RSV vaccines. The Cambridge, Massachusetts-based company ...
Moderna, Inc. (NASDAQ:MRNA) today announced that it has been awarded a tender for the supply of its mRNA COVID-19 vaccine in the European Union (EU), Norway and North Macedonia. Under the resulting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results